Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Conferences
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
 
NPG Resources
Bioentrepreneur
Nature Reviews Drug Discovery
Nature
Nature Medicine
Nature Genetics
Nature Reviews Genetics
Nature Methods
Nature Chemical Biology
news@nature.com
Clinical Pharmacology & Therapeutics
Nature Conferences
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Biotechnology  19, 235 - 241 (2001)
doi:10.1038/85677

An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans

Marianne D. De Backer1, Bart Nelissen1, Marc Logghe3, Jasmine Viaene3, Inge Loonen1, Sandy Vandoninck1, Ronald de Hoogt1, Sylviane Dewaele3, Fermin A. Simons1, Peter Verhasselt2, Greet Vanhoof2, Roland Contreras3 & Walter H.M.L. Luyten1

1  Department of Advanced Bio-Technologies, Janssen Pharmaceutica, Turnhoutseweg 30, B2340 Beerse, Belgium.

2  Department of Biotechnology and High Throughput Screening, Janssen Pharmaceutica, Turnhoutseweg 30, B2340 Beerse, Belgium.

3  Department of Molecular Biology, Subunit Fundamental and Applied Molecular Biology, University Gent and Vlaams Instituut voor de bevordering van het Wetenschappelijk Technologisch onderzoek in de industrie (IWT/VIB), K.L. Ledeganckstraat 35, B9000 Gent, Belgium.

Correspondence should be addressed to Marianne D. De Backer mdebacke@prius.jnj.com
Converting the complete genome sequence of Candida albicans into meaningful biological information will require comprehensive screens for identifying functional classes of genes. Most systems described so far are not applicable to C. albicans because of its difficulty with mating, its diploid nature, and the lack of functional random insertional mutagenesis methods. We examined artificial gene suppression as a means to identify gene products critical for growth of this pathogen; these represent new antifungal drug targets. To achieve gene suppression we combined antisense RNA inhibition and promoter interference. After cloning antisense complementary DNA (cDNA) fragments under control of an inducible GAL1 promoter, we transferred the resulting libraries to C. albicans. Over 2,000 transformant colonies were screened for a promoter-induced diminished-growth phenotype. After recovery of the plasmids, sequence determination of their inserts revealed the messenger RNA (mRNA) they inhibited or the gene they disrupted. Eighty-six genes critical for growth were identified, 45 with unknown function. When used in high-throughput screening for antifungals, the crippled C. albicans strains generated in this study showed enhanced sensitivity to specific drugs.

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Biotechnology
ISSN: 1087-0156
EISSN: 1546-1696
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | Conferences | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2001 Nature Publishing Group | Privacy policy